ARAHKEY技术在胸主动脉腔内修复术中股动脉穿刺口的管理中的应用  

The ARAHKEY technique:a novel method for the management of access site bleeding during percutaneous transfemoral thoracic aortic endovascular

作　　者：刘光锐[1] 韩晓峰[1] 李铁铮[1] 马晓海[1] 郭曦[1] Liu Guangrui;Han Xiaofeng;Li Tiezheng;Ma Xiaohai;Guo Xi(Deparment of Diagnostic and Interentional Radiology Beijing Anzhen Hospital,Capital Medical University,Beijing 100029 China)

机构地区：[1]首都医科大学附属北京安贞医院介入诊疗科,北京100029

出　　处：《中华胸心血管外科杂志》2024年第7期406-408,共3页Chinese Journal of Thoracic and Cardiovascular Surgery

摘　　要：目的回顾性研究评价ARAHKEY(使用与血管外缝合装置深度吻合的附加止血装置进行动脉封闭)技术在经皮胸主动脉疾病腔内修复术(TEVAR)中的安全性和有效性。方法 2021年1月至2023年1月202例患者在北京安贞医院接受了TEVAR。其中24例使用了ARAHKEY技术治疗, 即当使用2枚ProGlide预埋缝合不能达到止血效果时, 在股动脉穿刺部位额外使用1枚7F Exosel, 以达到止血效果。结果患者均达到完全止血。止血手术(5.8±2.6)min。未见复发性出血、感染和晚期获得性血肿等并发症。结论 ARAHKEY技术安全、有效, 当TEAVR期间使用ProGlide未达到止血效果时, 可作为首选。Objective:To evaluate the safety and effectiveness of ARAHKEY(arterial closure using an additional hemostatic device that is deeply compatible with an extravascular suturing device)technique during percutaneous transluminal repair of thoracic aortic disease(TEVAR).Methods:From January 2021 to January 2023,a total of 202 patients underwent TEVAR in our center.24 patients were treated with ARAHKEY technology,which involves using an additional 7F Exosel at the femoral artery puncture site to achieve hemostatic effect when two ProGlide embedded sutures cannot achieve hemostatic effect.Results:All patients achieved complete hemostasis.The mean time for compression hemostasis was(5.8±2.6)min.In this study cohort,no complications including recurrent bleeding,infection,and late acquired hematoma were observed.Conclusion:ARAHKEY technology is a safe method that can be considered as the primary choice when using ProGlide during TEAVR without achieving hemostatic effects.

关 键 词：胸主动脉 腔内修复 止血 

分 类 号：R655[医药卫生—外科学]